X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
female (12) 12
index medicus (12) 12
risk factors (12) 12
anticoagulants - adverse effects (11) 11
anticoagulants - therapeutic use (11) 11
male (11) 11
medicine, general & internal (11) 11
deep-vein thrombosis (9) 9
aged (8) 8
middle aged (8) 8
abridged index medicus (7) 7
drug therapy (7) 7
hemorrhage - chemically induced (7) 7
thrombosis (7) 7
anticoagulants (6) 6
blood clots (6) 6
clinical trials (6) 6
risk (6) 6
thromboembolism (6) 6
treatment outcome (6) 6
warfarin (6) 6
aged, 80 and over (5) 5
anticoagulants - administration & dosage (5) 5
heparin - therapeutic use (5) 5
prevention (5) 5
respiratory system (5) 5
studies (5) 5
surgery (5) 5
veins & arteries (5) 5
venous thrombosis (5) 5
venous thrombosis - drug therapy (5) 5
care and treatment (4) 4
critical care medicine (4) 4
deep vein thrombosis (4) 4
diagnosis (4) 4
dosage and administration (4) 4
hemorrhage - prevention & control (4) 4
management (4) 4
molecular-weight heparin (4) 4
peripheral vascular disease (4) 4
recurrence (4) 4
research (4) 4
venous thrombosis - diagnostic imaging (4) 4
warfarin - administration & dosage (4) 4
administration, oral (3) 3
adult (3) 3
antithrombotic therapy (3) 3
aspirin (3) 3
cardiovascular (3) 3
complications (3) 3
compression therapy (3) 3
double-blind (3) 3
health aspects (3) 3
hematology (3) 3
heparin (3) 3
heparin - adverse effects (3) 3
incidence (3) 3
international normalized ratio (3) 3
intravenous unfractionated heparin (3) 3
mortality (3) 3
outcomes (3) 3
patients (3) 3
postoperative complications - prevention & control (3) 3
postthrombotic syndrome - prevention & control (3) 3
quality of life (3) 3
quality-of-life (3) 3
time factors (3) 3
venous thromboembolism (3) 3
venous thromboembolism - drug therapy (3) 3
warfarin - adverse effects (3) 3
warfarin - therapeutic use (3) 3
whole-blood assay (3) 3
1st episode (2) 2
adjusted subcutaneous heparin (2) 2
algorithms (2) 2
animals (2) 2
atrial fibrillation - drug therapy (2) 2
bleeding (2) 2
burden (2) 2
cardiac & cardiovascular systems (2) 2
catheters (2) 2
complications and side effects (2) 2
compression stockings (2) 2
definition (2) 2
determinants (2) 2
diagnostic tests (2) 2
disease (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
embolisms (2) 2
fatal pulmonary-embolism (2) 2
fibrin fibrinogen degradation products - analysis (2) 2
fibrinolytic agents - therapeutic use (2) 2
follow-up studies (2) 2
heart (2) 2
heart attacks (2) 2
heart-valve replacement (2) 2
hemorrhage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9920, pp. 880 - 888
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 142, Issue 4, pp. 1075 - 1076
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 10, pp. 1393 - 1395
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 23, pp. 2240 - 2252
Journal Article
by Devereaux, P J and Duceppe, Emmanuelle and Guyatt, Gordon and Tandon, Vikas and Rodseth, Reitze and Biccard, Bruce M and Xavier, Denis and Szczeklik, Wojciech and Meyhoff, Christian S and Vincent, Jessica and Franzosi, Maria Grazia and Srinathan, Sadeesh K and Erb, Jason and Magloire, Patrick and Neary, John and Rao, Mangala and Rahate, Prashant V and Chaudhry, Navneet K and Mayosi, Bongani and de Nadal, Miriam and Iglesias, Pilar Paniagua and Berwanger, Otavio and Villar, Juan Carlos and Botto, Fernando and Eikelboom, John W and Sessler, Daniel I and Kearon, Clive and Pettit, Shirley and Sharma, Mukul and Connolly, Stuart J and Bangdiwala, Shrikant I and Rao-Melacini, Purnima and Hoeft, Andreas and Yusuf, Salim and Devereaux, P.J and Duceppe, Emmanuelle and Bangdiwala, Shrikant I and Connolly, Stuart and Eikelboom, John and Guyatt, Gordon and Kearon, Clive and Pettit, Shirley and Pogue, Janice and Rodseth, Reitze and Sessler, Daniel I and Vincent, Jessica and Yusuf, Salim and Di Diodato, Sara and Gasic, Zora and Mastrangelo, Louise J and Molnar, Sarah H and Swanson, Jennifer L and Tosh, Makayla L and Wells, Jennifer R and Botto, Fernando and Diaz, Rafael and Chow, Clara K and Berwanger, Otavio and Gonzales, Beatriz and Tandon, Vikas and Villar, Juan Carlos and Vásquez, Skarlet and Jansky, Petr and Dušek, Radovan and Meyhoff, Christian S and Coriat, Pierre and Hoeft, Andreas and Wittmann, Maria and Yonga, Gerald and Xavier, Denis and Rao, Mangala and Mathur, Nandini and Franzosi, Maria Grazia and Seletti, Elena and Malaga, German and Tumanan-Mendoza, Bernadette A and Tagle, Maria Pamela A and Szczeklik, Wojciech and Biccard, Bruce M and Alonso-Coello, Pablo and Popova, Ekaterine and Shields, Martin and Le Manach, Yannick and Moayyedi, Paul and van Zanten, Sander and Fleischmann, Edith and Garg, Amit and Karaye, Kamilu and McFalls, Edward and Sigamani, Alben and Belley-Côté, Emilie and Biedroń, Grzegorz and Borges, Flavia and Frosi Stella, Steffan and Haarmark Nielsen, Christian and Leong, Darryl P and Spence, Jessica and Tran, Allen and Wawrzycka-Adamczyk, Katarzyna and Yang, Stephen S and ... and MANAGE Investigators
The Lancet, ISSN 0140-6736, 06/2018, Volume 391, Issue 10137, pp. 2325 - 2334
Myocardial injury after non-cardiac surgery (MINS) increases the risk of cardiovascular events and deaths, which anticoagulation therapy could prevent.... 
DEFINITION | MORTALITY | MEDICINE, GENERAL & INTERNAL | THERAPY | EVENTS | RIVAROXABAN | DOUBLE-BLIND | ELEVATION | ACUTE CORONARY SYNDROMES | ASPIRIN | Troponin - drug effects | Dabigatran - adverse effects | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Dabigatran - administration & dosage | Humans | Stroke - complications | Male | Hemorrhage - prevention & control | Peripheral Arterial Disease - complications | Venous Thromboembolism - drug therapy | Antithrombins - pharmacology | Venous Thromboembolism - prevention & control | Aged, 80 and over | Female | Dabigatran - pharmacology | Troponin - metabolism | Omeprazole - therapeutic use | Stroke - prevention & control | Placebo Effect | Omeprazole - administration & dosage | Perioperative Period - mortality | Hemorrhage - complications | Peripheral Arterial Disease - drug therapy | Treatment Outcome | Stroke - drug therapy | Proton Pump Inhibitors - therapeutic use | Peripheral Arterial Disease - prevention & control | Thrombosis - pathology | Hemorrhage - drug therapy | Myocardial Infarction - drug therapy | Aged | Clinical trials | Anesthesia | Care and treatment | Analysis | Cardiac patients | Heart | Myocardial infarction | Cardiac arrhythmia | Heart attacks | Embolisms | Heart surgery | Risk | Cardiovascular disease | Family medical history | Evidence-based medicine | Bleeding | Randomization | Motivation | Safety engineering | Surgery | Amputation | Safety | Thromboembolism | Heart diseases | Anticoagulants | Cerebral infarction | Stroke | Aspirin | Complications | Mortality | Health risks | Patients | Thrombosis | Omeprazole | Sepsis | Infarction | Adults | Cardiovascular diseases | Health risk assessment | Factorial design
Journal Article